SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Abgenix, Inc. (ABGX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (342)7/20/2004 5:28:05 PM
From: Icebrg  Read Replies (1) of 590
 
Abgenix names Ringo as new president, CEO
Tuesday July 20, 5:13 pm ET

LOS ANGELES, July 20 (Reuters) - Biopharmaceutical company Abgenix Inc. (NasdaqNM:ABGX - News) on Tuesday said it has named William R. Ringo as its new president and chief executive officer replacing Ray Withy who is stepping down as of August 30.

"Abgenix has made significant progress in its evolution into a product development company and the time is now right to bring a new leader into the company with strong operating, marketing and commercialization experience," Chairman R. Scott Greer said in a statement.

Ringo will sit on the board of directors, and Withy will continue as a board member of the Fremont, California company.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext